Activated protein C reduces intestinal injury in an experimental model of necrotizing enterocolitis

Journal of Pediatric Surgery

Volumn 45, Issue 3, 2010, Pages 483-489

  Kumral, Abdullah ^a   Yesilirmak, Didem C ^a   Tugyan, Kazim ^a   Baskin, Huseyin ^a   Tekman, Isil ^a   Duman, Nuray ^a   Ozkan, Hasan ^a  

^a DOKUZ EYLUL UNIVERSITY   (Turkey)

Author keywords

Activated protein C; Necrotizing enterocolitis; Newborn

Indexed keywords

ACTIVATED PROTEIN C; CARBON DIOXIDE; INTERLEUKIN 1BETA; INTERLEUKIN 6; NITRIC OXIDE; NITRITE; OXYGEN; SODIUM CHLORIDE; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CELL PROTECTION; CONTROLLED STUDY; HISTOPATHOLOGY; HYPOXIA; INJURY SCALE; INTESTINE CELL; INTESTINE INJURY; NECROTIZING ENTEROCOLITIS; NEWBORN; NONHUMAN; PRIORITY JOURNAL; RAT; REOXYGENATION;

ANIMALS; ANIMALS, NEWBORN; ANTICOAGULANTS; BIOPSY, NEEDLE; CELL DEATH; CYTOKINES; DISEASE MODELS, ANIMAL; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG ADMINISTRATION SCHEDULE; ENTEROCOLITIS, NECROTIZING; IMMUNOHISTOCHEMISTRY; INJECTIONS, INTRAPERITONEAL; INTESTINAL MUCOSA; INTESTINES; NITRIC OXIDE; PROBABILITY; PROTEIN C; RANDOM ALLOCATION; RATS; RATS, WISTAR; REFERENCE VALUES; STATISTICS, NONPARAMETRIC;

EID: 77649216557     PISSN: 00223468     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jpedsurg.2009.07.077     Document Type: Article

References (37)

1. Esmon C.T., and Fukudome K. Cellular regulation of the protein C pathway. Semin Cell Biol 6 (1995) 259-268
2. Taylor F.B., Peer G.T., Lockhart M.S., et al. Endothelial cell protein C receptor plays an important role in protein C activation in vivo. Blood 97 (2001) 1685-1688
3. Walker F.J., Sexton P.W., and Esmon C.T. The inhibition of blood coagulation by activated Protein C through the selective inactivation of activated Factor V. Biochim Biophys Acta 571 (1979) 333-342
4. Griffin J.H., Zlokovic B., and Fernandez J.A. Activated protein C: potential therapy for severe sepsis, thrombosis, and stroke. Semin Hematol 39 (2002) 197-205
5. Hirose K., Okajima K., Taoka Y., et al. Activated protein C reduces the ischemia/reperfusion-induced spinal cord injury in rats by inhibiting neutrophil activation. Ann Surg 232 (2000) 272-280
6. Mizutani A., Okajima K., Uchiba M., et al. Activated protein C reduces ischemia/reperfusion-induced renal injury in rats by inhibiting leukocyte activation. Blood 95 (2000) 3781-3787
7. Schoots I.G., Levi M., van Vliet A.K., et al. Inhibition of coagulation and inflammation by activated protein C or antithrombin reduces intestinal ischemia/reperfusion injury in rats. Crit Care Med 32 (2004) 1375-1383
8. Shibata M., Kumar S.R., Amar A., et al. Anti-inflammatory, antithrombotic, and neuroprotective effects of activated protein C in a murine model of focal ischemic stroke. Circulation 103 (2001) 1799-1805
9. Dillon J.P., Laing A.J., Cahill R.A., et al. Activated protein C attenuates acute ischaemia reperfusion injury in skeletal muscle. J Orthop Res 23 (2005) 1454-1459
10. Levi M., Choi G., Schoots I., et al. Beyond sepsis: activated protein C and ischemia-reperfusion injury. Crit Care Med 32 (2004) 309-312
11. Lin P.W., and Stoll B.J. Necrotising enterocolitis. Lancet 368 (2006) 1271-1283
12. Gribar S.C., Anand R.J., Sodhi C.P., et al. The role of epithelial Toll-like receptor signaling in the pathogenesis of intestinal inflammation. J Leukoc Biol 83 (2008) 493-498
13. Engum S.A., and Grosfeld J.L. Necrotizing enterocolitis. Curr Opin Pediatr 10 (1998) 123-130
14. Puiman P., and Stoll B. Animal models to study neonatal nutrition in humans. Curr Opin Clin Nutr Metab Care 11 (2008) 601-606
15. Holman R.C., Stoll B.J., Clarke M.J., et al. The epidemiology of necrotizing enterocolitis mortality in the United States. Am J Public Health 87 (1997) 2026-2031
16. Stechmiller J.K., Treloar D., and Allen N. Gut dysfunction in critically ill patients: a review of the literature. Am J Crit Care 6 (1997) 204-209
17. Gollin G., Zieg P.M., and Cohn S.M. Intestinal mucosal injury in critically ill surgical patients: preliminary observations. Am Surg 65 (1999) 19-21
18. Yesilirmak D.C., Kumral A., Tugyan K., et al. Effects of activated protein C on neonatal hypoxic ischemic brain injury. Brain Res 1210 (2008) 56-62
19. Ozer E.A., Kumral A., Ozer E., et al. Effect of retinoic acid on oxygen-induced lung in the newborn rat. Pediatr Pulmonol 39 (2005) 35-40
20. Musemeche C.A., Baker J.L., and Feddersen R.M. A model of intestinal ischemia in the neonatal rat utilizing superior mesenteric artery occlusion and intraluminal platelet-activating factor. J Surg Res 58 (1995) 724-727
21. Kumral A., Baski{dotless}n B., Duman N., et al. Erythropoietin protects against necrotizing enterocolitis of newborn rats by the inhibiting nitric oxide formation. Biol Neonate 84 (2003) 325-329
22. Heijmans C., Wesseldijk F., Munnikes R., et al. Multiplex bead array assay for detection of 25 soluble cytokines in blister fluid of patients with complex regional pain syndrome type 1. Mediators Inflamm 1 (2006) 1-8
23. Furukawa M., Lee E.L., and Johnston J.M. Platelet activating factor-induced ischemic bowel necrosis. The effect of platelet-activating factor acetylhydrolase. Pediatr Res 34 (1993) 237-241
24. Caplan M.S., Sun X.M., Hsueh W., et al. Role of platelet-activating factor and tumor necrosis factor-alpha in neonatal necrotizing enterocolitis. J Pediatr 116 (1990) 960-964
25. Wong S.S., Sun N.N., Hyde J.D., et al. Drotrecogin alfa (activated) prevents smoke-induced increases in pulmonary microvascular permeability and proinflammatory cytokine IL-1 beta in rats. Lung 182 (2004) 319-330
26. Chen C.M., Hou C.C., Cheng K.C., et al. Activated protein C therapy in a rat heat stroke model. Crit Care Med 34 (2006) 1960-1966
27. Contreras J.L., Eckstein C., Smyth C.A., et al. Activated protein C preserves functional islet mass after intraportal transplantation: a novel link between endothelial cell activation, thrombosis, inflammation, and islet cell death. Diabetes 53 (2004) 2804-2814
28. Holub M., Helcl M., Beran O., et al. Kinetics of immune parameters in a patient with sepsis caused by Streptococcus pyogenes treated with activated protein C. Scand J Infect Dis 36 (2004) 485-488
29. Yuksel M., Okajima K., Uchiba M., et al. Activated protein C inhibits lipopolysaccharide-induced tumor necrosis factor-alpha production by inhibiting activation of both nuclear factor-kappa B and activator protein-1 in human monocytes. Thromb Haemost 88 (2002) 267-273
30. Franscini N., Bachli E.B., Blau N., et al. Gene expression profiling of inflamed human endothelial cells and influence of activated protein C. Circulation 110 (2004) 2903-2909
31. Joyce D.E., and Grinnell B.W. Recombinant human activated protein C attenuates the inflammatory response in endothelium and monocytes by modulating nuclear factorkappaB. Crit Care Med 30 (2002) 288-293
32. Whittle B.J., Boughton-Smith N.K., and Moncada S. Biosynthesis and role of the endothelium-derived vasodilator, nitric oxide, in the gastric mucosa. Ann NY Acad Sci 664 (1992) 126-129
33. Chokshi N.K., Guner Y.S., Hunter C.J., et al. The role of nitric oxide in intestinal epithelial injury and restitution in neonatal necrotizing enterocolitis. Semin Perinatol 32 (2008) 92-99
34. Tepperman B.L., Brown J.F., and Whittle B.J. Nitric oxide synthase induction and intestinal epithelial cell viability in rats. Am J Physiol 265 (1993) 214-218
35. Ford H., Watkins S., Reblock K., et al. The role of inflammatory cytokines and nitric oxide in the pathogenesis of necrotizing enterocolitis. J Pediatr Surg 32 (1997) 275-282
36. Guo H., Liu D., Gelbard H., Cheng T., et al. Activated protein C prevents neuronal apoptosis via protease activated receptors 1 and 3. Neuron 41 (2004) 563-572
37. Joyce D.E., Gelbert L., Ciaccia A., et al. Gene expression profile of antithrombotic protein c defines new mechanisms modulating inflammation and apoptosis. J Biol Chem 276 (2001) 11199-11203